Results 101 to 110 of about 63,125 (287)
Policy Points States contract with Medicaid managed care plans to administer benefits for roughly 70 million Medicaid enrollees, yet little is known about how plan benefit policies for substance use disorder (SUD) treatment medications align with state requirements.
SAGE R. FELTUS +6 more
wiley +1 more source
Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
Introduction: Emergency departments (EDs) may be high-yield venues to address opioid deaths with education on both overdose prevention and appropriate actions in a witnessed overdose.
Dwyer, Kristin +6 more
doaj +1 more source
Abstract Drug entry into prisons represents a serious issue for both incarcerated people and prison staff. Although substances enter prisons in many ways, staff drug smuggling represents a consistent problem facing correctional institutions globally. We draw on 131 interviews with correctional officers (COs) working in four Western Canadian prisons to ...
William J. Schultz +2 more
wiley +1 more source
Integrating Harm Reduction and Trauma‐Informed Care in Undergraduate Dental Education
Journal of Dental Education, EarlyView.
Malak Abuhatem +3 more
wiley +1 more source
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley +1 more source
Implementation and Evaluation of a Bystander Naloxone Training Course
Introduction: Bystander provision of naloxone is a key modality to reduce opioid overdose-related death. Naloxone training courses are available, but no standardized program exists.
Scott G. Weiner +7 more
doaj +1 more source
Comprehensive User Engagement Sites (CUES) in Philadelphia: A Constructive Proposal [PDF]
This paper is a study about Philadelphia’s comprehensive user engagement sites (CUESs) as the authors address and examine issues related to the upcoming implementation of a CUES while seeking solutions for its disputed questions and plans. Beginning with
Clark, Peter +12 more
core
Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen +7 more
wiley +1 more source
Abstract Background and aims The state of Kentucky has been heavily impacted by the ongoing opioid crisis in the United States, with high overdose mortality, high prevalence of opioid use disorder (OUD), elevated maternal mortality and incidence of Neonatal Abstinence Syndrome.
Hilary L. Surratt +9 more
wiley +1 more source
Abstract Background and aims There are currently no brief quantitative assessments that capture the drug patterns of people who engage in use of more than one drug on the same day or simultaneously. The current study examined the retest reliability, acceptability and feasibility of a new quantitative assessment to measure polysubstance use.
Amanda M. Bunting +7 more
wiley +1 more source

